glp 1 and iih GLP-1 medications pseudotumor cerebri / idiopathic intracranial hypertension #pseudotumorcerebri #iih The effect of GLP-1 agonist

These findings align closely with prior cardiovascular outcome trials and solidify the evidence base by demonstrating consistent benefits in broader patient populations treated in clinical practice

Small decreases are noted between ages 30 and 50, and decreases accelerate after the fifth decade of life, with some people experiencing as much as a 15 percent strength loss per decade, with more than 50 percent of fast twitch muscle fibers being lost by 75 years of age

You'll still get some GH elevation, but peak levels will be significantly lower and duration shorter

Receive Ongoing Support From order updates to formulation questions, our team stays connected every step of the way

10.1016/j.nlm.2021.107463 189 ZhangL

For 76% of women, the main reason for starting GLP-1 medication is to improve physical appearance, while 72% of men cite health concerns as their primary motivation